Rocket Lab reported $436.21 million in revenue for its most recent fiscal year, with a net loss of $190.18 million. The company’s earnings per share stood at negative $0.38, reflecting continued investment in R&D and infrastructure. At a price-to-sales ratio of 93.05 and a trailing price-to-earnings ratio of –199.97, Rocket Lab trades at a premium valuation relative to its revenue base, underscoring market expectations for rapid growth in small-satellite launch demand.

In 2025 Rocket Lab achieved a record 21 Electron rocket launches, marking its highest annual launch cadence and reaching 100% mission success. Among these missions was the deployment of the QPS-SAR-15 synthetic-aperture radar satellite for the Institute for Q-shu Pioneers of Space, the seventh satellite Rocket Lab has placed into that constellation. With a total of 79 Electron missions completed to date, the company has secured seven additional launches for the iQPS network beginning in early 2026, and plans to expand dedicated missions for civil space agencies in Japan and Europe as well as hypersonic-technology test flights for national security customers.

Rocket Lab’s stock exhibits a beta of 2.16, indicating volatility more than double that of the S&P 500 benchmark. Institutional investors hold 71.8% of shares, and insiders account for 11.9%, suggesting strong confidence among large-scale and management stakeholders. According to the latest consensus, analysts have issued 1 sell rating, 5 holds, 7 buys and 2 strong buys, yielding a composite score of 2.67 on a 1–5 scale. While profitability metrics remain challenged—net margins of –35.64%, return on equity of –27.26% and return on assets of –12.21%—investor attention is focused on Rocket Lab’s established launch record and backlog of mission commitments.